Most of the guidelines are conditional but represent the best of evidence-based treatments for psoriatic arthritis.
Translational work combining human plasma studies and previous mouse model data will enable identification of new, precise biomarkers and potential treatment pathways that may help pinpoint and treat RA and PsA patients at increased risk of CV disease.
Golimumab is safe and effective for treating PsA, according to the 24-week report of the GO-VIBRANT study.
Here’s why psoriatic arthritis is among the first clinical areas Cleveland Clinic’s collaborative Center for Clinical Genomics has chosen to focus on.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The Husni research lab combines clinical savvy with biochemical and molecular biology expertise to home in on the molecular basis of immune-mediated diseases. An early focus: selective TNF-α receptor inhibition.
Here’s early evidence that activity levels of HDL-associated antioxidant enzymes might prove to be a much-needed predictor of cardiovascular risk in systemic rheumatic diseases.
Updated treatment guidelines from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis include a section on managing comorbidities and extra-articular manifestations in psoriatic arthritis patients.
Carotid ultrasound is a pragmatic way to assess cardiac risk in patients with psoriatic arthritis and identify those who would benefit from early interventions